about
Tracking genomic cancer evolution for precision medicine: the lung TRACERx studyCerebral air embolism following transbronchial lung biopsy during flexible bronchoscopy.Transcriptome analysis shows activation of circulating CD8+ T cells in patients with severe asthma.Clinical expert guidelines for the management of cough in lung cancer: report of a UK task group on coughPulmonary artery sarcoma: a rare thoracic tumor frequently misdiagnosed at presentationThe Manchester cough in lung cancer scale: the development and preliminary validation of a new assessment tool.The impact on the multidisciplinary team of molecular profiling for personalized therapy in non-small cell lung cancer.Summary of the British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults.Emerging role of MicroRNAs and long noncoding RNAs in respiratory disease.HUWE1 ubiquitylates and degrades the RAC activator TIAM1 promoting cell-cell adhesion disassembly, migration, and invasion.Olanzapine-induced eosinophilic pleuritis.British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE.Sarcomatoid mesothelioma with osteoid differentiation.The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trials.EBUS-TBNA in elderly patients with lung cancer: safety and performance outcomes.Can computed tomography characteristics predict outcomes in patients undergoing radial endobronchial ultrasound-guided biopsy of peripheral lung lesions?Considerations in developing and delivering a nonpharmacological intervention for symptom management in lung cancer: the views of patients and informal caregivers.Can EBUS-TBNA provide an accurate diagnosis in patients found to have enlarged or FDG-avid lymph nodes during surveillance of previously treated lung cancer? A retrospective study.Referral patterns for mediastinal staging with EBUS across a UK Lung Cancer Network: A report from the Manchester Cancer EBUS sub-group.Thoracic metastasis from renal cell carcinoma: bronchoscopic and EBUS images.Considerations in developing and delivering a non-pharmacological intervention for symptom management in lung cancer: the views of health care professionalsA phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic OncologyAchieving a tissue diagnosis in PS3 patients with advanced lung cancer: What are the safety and diagnostic outcomes with EBUS?Endobronchial Ultrasound ImagesNodal Staging in Lung Cancer: A Risk Stratification Model for Lymph Nodes Classified as Negative by EBUS-TBNAShould All Lung Cancer Patients Requiring Mediastinal Staging With EBUS Undergo PET-CT First?Individualised treatment in non-small cell lung cancer: precise tissue diagnosis for all?Images in clinical medicine. Bronchoalveolar-cell carcinomaVaricosities of the valleculae: an unusual cause of hemoptysis?Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum-based chemotherapy in advanced nonsmall cell lung cancerStage distribution and performance status of newly diagnosed patients in a UK regional mesothelioma centreSequential screening for lung cancer in a high-risk group: randomised controlled trial: LungSEARCH: a randomised controlled trial of Surveillance using sputum and imaging for the EARly detection of lung Cancer in a High-risk group
P50
Q28655985-A6594EB9-20F3-49E7-9AA9-17372DFA6D00Q33770589-C947857E-37A3-4FDD-8089-E02846B61828Q34216291-DFCC6233-5A0B-4AC3-8123-47D82D122E71Q34297098-2452B741-B9B2-43B5-BCDE-9800CBAB24B4Q36247907-8EA7F3D3-D154-43E9-A8D5-EB0B34682976Q38038428-F67FE8EF-0FB3-481E-B67D-F9AE2A5F99AFQ38062608-6412BF51-962B-4AB9-AE28-3612B3BB2696Q38120674-B410B8E9-E83F-4AEA-A8F7-552E97D6951EQ38228031-D0FB3406-9DD6-41FB-BDFE-635295FDFACDQ42101475-4A1DF646-789B-44AD-B68C-BDCC48ACE92AQ43182884-34B59815-C247-45EB-A1C4-D46DB51EA73DQ43510545-A8D62D9A-6FA2-43F7-9542-627F3D453B54Q44330036-B64AFFE6-741F-4807-B113-C9746A8C5A30Q44934727-D0384942-05F2-4A95-B893-63004CE77E60Q44970209-F82DF182-9B54-4C88-AF7A-C00BA12FFF28Q45236898-CE7740BA-242D-4C2A-8E89-5C13465BBD55Q47657297-AD1D96D8-0688-4AAF-82A1-29F87E076155Q50562989-96F27980-7B05-49F0-906A-BAC68233D2D7Q51656636-0917B25D-55DE-4B84-B4E8-FFCEF28E39F5Q53030674-D7F4A8C7-121E-4E4F-8082-AA07546C00E7Q57423026-7C118A34-0F3F-4BF8-875D-2036260FD91BQ57569726-69900A26-D207-44B9-82A7-BA2D3604BF75Q59305104-BF2BA242-E495-4104-8D0C-9BE7C72B2760Q59305105-7A4EAC7C-5816-429C-BC23-188F5E54CACBQ59305106-0848757F-757A-4ED8-AB84-2CC52341367EQ59305107-6AA270D1-C3C5-48C0-A236-10D21DFF7D95Q60620730-D9BA67DC-C622-4778-884B-F1AAF88C9EF4Q77471742-DFFC3F71-BE1C-4D9C-8F36-EDAF88493832Q77504569-C38B87B0-F909-4D33-8848-0582C34AC44EQ83223958-EADF521E-DA9F-4F89-B103-EA57E3D89A20Q87779301-CBD941EE-C71D-47D6-9ECF-7A22FF11B783Q90182609-25FF3795-8358-42DD-9734-8EA7F73CF1C8
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Richard Booton
@ast
Richard Booton
@en
Richard Booton
@es
Richard Booton
@nl
Richard Booton
@sl
type
label
Richard Booton
@ast
Richard Booton
@en
Richard Booton
@es
Richard Booton
@nl
Richard Booton
@sl
prefLabel
Richard Booton
@ast
Richard Booton
@en
Richard Booton
@es
Richard Booton
@nl
Richard Booton
@sl
P106
P1153
6603721721
P21
P31
P496
0000-0003-4512-2899